MIG (CXCL9) CHEMOKINE IS A KEY BIOMARKER THAT DISCRIMINATES BETWEEN PEDIATRIC IBD PATIENTS AND NON-IBD PATIENTS IN A NOVEL BIOMARKER MODEL

Adi Eindor ¹ Kevin Tsai ² Kevan Jacobson ²
¹ Shamir Medical Center, Zeriffin, Israel
² BC Children's Hospital, Vancouver, Canada

Topic
IBD

Session
PP 05 IBD (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)

Do you need help setting up your myUEG account?
Contact us at [email protected]

Social Sharing